Changes in cell culture temperature alter release of inflammatory mediators in murine macrophagic RAW264.7 cells

Inflammation Research

Volumn 56, Issue 7, 2007, Pages 297-303

  Hagiwara, S ^a   Iwasaka, H ^a   Matsumoto, S ^a   Noguchi, T ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Cytokine; HMGB1; Hyperthermia; Hypothermia; LPS

Indexed keywords

CYTOKINE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PROTEIN P50; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BODY TEMPERATURE; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; HYPERTHERMIA; HYPOTHERMIA; INFLAMMATION; MACROPHAGE; MEASUREMENT; MEDIATOR RELEASE; MOUSE; NONHUMAN; SUPERNATANT; TEMPERATURE SENSITIVITY;

EID: 34447635743     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-007-6161-z     Document Type: Article

References (46)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303-10
2. Tsiotou AG, Sakorafas GH. Management of septic shock: current concepts, with a particular emphasis on the role of source control, and future perspectives. Eur J Anaesthesiol 2004; 21: 337-60.
3. Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol 1999; 19: 5237-46
4. Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH et al. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 2003; 101: 2652-60.
5. Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim JY, Strassheim D et al. High Mobility Group Box 1 protein (HMGB1) interacts with multiple toll-like receptors. Am J Physiol Cell Physiol 2006; 290: 917-24.
6. Kokkola R, Andersson A, Mullins G, Ostberg T, Treutiger CJ, Arnold B et al. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol 2005; 61: 1-9.
7. Hatada T, Wada H, Nobori T, Okabayashi K, Maruyama K, Abe Y et al. Plasma concentrations and importance of High Mobility Group Box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation. Thromb Haemost 2005; 94: 975-9.
8. Sunden-Cullberg J, Norrby-Teglund A, Rouhiainen A, Rauvala H, Herman G, Tracey KJ et al. Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit Care Med 2005; 33: 564-73.
9. Kluger MJ, Kozak W, Conn CA, Leon LR, Soszynski D. Role of fever in disease. Ann NY Acad Sci 1998; 856: 224-33.
10. Jiang Q, Cross AS, Singh IS, Chen TT, Viscardi RM, Hasday JD. Febrile core temperature is essential for optimal host defense in bacterial peritonitis. Infect Immun 2000; 68: 1265-70.
11. Dong HP, Chen HW, Hsu C, Chiu HY, Lin LC, Yang RC. Previous heat shock treatment attenuates lipopolysaccharide-induced hyporesponsiveness of platelets in rats. Shock 2005; 24: 239-44.
12. Doufas AG, Sessler DI. Physiology and clinical relevance of induced hypothermia. Neurocrit Care 2004; 1: 489-98.
13. Gundersen Y, Vaagenes P, Pharo A, Valo ET, Opstad PK. Moderate hypothermia blunts the inflammatory response and reduces organ injury after acute haemorrhage. Acta Anaesthesiol Scand 2001 Sep; 45(8): 994-1001.
14. Morrison AL, Dinges M, Singleton KD, Odoms K, Wong HR, Wischmeyer PE. Glutamine's protection against cellular injury is dependent on heat shock factor-1. Am J Physiol Cell Physiol 2006; 290: C1625-32.
15. Wang Z, Kang JS, Li Y, Yuan ZX, Liu SS, Sun LK. The effects of dexamethasone on rat brain cortical nuclear factor kappa B (NF-kappaB) in endotoxic shock. Toxicol Appl Pharmacol 2006; 214: 263-9.
16. Chen Y, Currie RW. Heat shock treatment suppresses angiotensin II-induced SP-1 and AP-1 and stimulates Oct-1 DNA-binding activity in heart. Inflamm Res 2005; 54: 338-43.
17. Ulloa L, Messmer D. High-mobility group box 1 (HMGB1) protein: friend and foe. Cytokine Growth Factor Rev. 2006; 17: 189-201.
18. Richard I. Morimoto. Regulation of the heat shock transcriptional response: cross talk between a family of heat shock factors, molecular chaperones, and negative regulators. Genes Dev 1998; 12: 3788-96.
19. Kampinga HH. Thermotolerance in mammalian cells. Protein denaturation and aggregation, and stress proteins. J Cell Sci 1993; 104: 11-7.
20. Schell MT, Spitzer AL, Johnson JA, Lee D, Harris HW. Heat shock inhibits NF-kB activation in a dose- and time-dependent manner, Journal of Surgical Research 2005; 129: 90-3.
21. King TA, Ghazaleh RA, Juhn SK, Adams GL, Ondrey FG. Induction of heat shock protein 70 inhibits NF-kappa-B in squamous cell carcinoma, Otolaryngology and Head and Neck Surgery 2005; 133: 70-9.
22. Redaelli CA, Wagner M, Kulli C, Tian YH, Kubulus D, Mazzucchelli L et al. Hyperthermia-induced HSP expression correlates with improved rat renal isograft viability and survival in kidneys harvested from non-heart-beating donors. Trnspl Int 2001; 14: 351-60.
23. Cornelussen R, Spiering W, Webers JH, De Bruin LG, Reneman RS, van der Vusse GJ et al. Heat shock improves ischemic tolerance of hypertrophied rat hearts. Am J Physol 1994; 267: 1941-7.
24. Schueller G, Stift A, Friedl J, Dubsky P, Bachleitner-Hofmann T, Benkoe T et al. Hyperthermia improves cellular immune response to human hepatocellular carcinoma subsequent to co-culture with tumor lysate pulsed dendritic cells. Int J Oncol 2003; 22: 1397-402.
25. Jampel HD, Duff GW, Gershon RK, Atkins E, Durum SK. Fever and immunoregulation. III. Hyperthermia augments the primary in vitro humoral immune response. J Exp Med 1983; 157: 1229-38.
26. Marion DW. Moderate hypothermia in severe head injuries: the present and the future. Curr Opin Crit Care 2002; 8: 111-4.
27. Wagner BP, Nedelcu J, Martin E. Delayed postischemic hypothermia improves long-term behavioral outcome after cerebral hypoxia-ischemia in neonatal rats. Pediatr Res 2002; 51: 354-60.
28. Wu X, Stezoski J, Safar P, Bauer A, Tuerler A, Schwarz N et al. Mild hypothermia during hemorrhagic shock in rats improves survival without significant effects on inflammatory responses. Crit Care Med 2003; 31: 195-202.
29. Kentner R, Rollwagen FM, Prueckner S, Behringer W, Wu X, Stezoski J et al. Effects of mild hypothermia on survival and serum cytokines in uncontrolled hemorrhagic shock in rats. Shock 2002; 17: 521-6.
30. Paterson DL, Staplefeldt WH, Wagener MM, Gayowski T, Marino IR, Singh N. Intraoperative hypothermia is an independent risk factor for early cytomegalovirus infection in liver transplant recipients. Transplantation 1999; 67: 1151-5.
31. Sheffield CW, Sessler DI, Hunt TK. Mild hypothermia during isoflurane anesthesia decreases resistance to E. coli dermal infection in guinea pigs. Acta Anethesiol Scand 1994; 38: 201-5.
32. Beal MW, Brown DC, Shofer FS. The effects of perioperative hypothermia and the duration of anesthesia on postoperative wound infection rate in clean wounds: a retrospective study. Vet Surg 2000; 29: 123-7.
33. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285: 248-51.
34. Ding XZ, Fernandez-Prada CM, Bhattacharjee AK, Hoover DL. Over-expression of hsp-70 inhibits bacterial lipopolysaccharide-induced production of cytokines in human monocyte-derived macrophages. Cytokine 2001; 16: 210-9.
35. Shi Y, Tu Z, Tang D, Zhang H, Liu M, Wang K et al. The inhibition of LPS-induced production of inflammatory cytokines by HSP70 involves inactivation of the NF-kappaB pathway but not the MAPK pathways. Shock 2006; 26: 277-84.
36. Wang H, Liao H, Ochani M, Justiniani M, Lin X, Yang L et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 2004; 10: 1216-21.
37. Dumitriu IE, Baruah P, Valentinis B, Voll RE, Herrmann M, Nawroth PP et al. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J Immunol 2005; 174: 7506-15.
38. Dinarello CA. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 1997; 112: 321-9.
39. Kulmatycki KM, Jamali F. Therapeutic relevance of altered cytokine expression. Cytokine 2001; 14: 1-10.
40. Luheshi G, Rothwell N. Cytokines and fever. Int Arch Allergy Immunol 1996; 109: 301-7.
41. Scholz H. Fever. Am J Physiol Regul Integr Comp Physiol 2003; 284: 913-5.
42. Wang H, Vishnubhakat JM, Bloom O, Zhang M, Ombrellino M, Sama A et al. Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 1999; 126: 389-92.
43. Grunenfelder J, Zund G, Stucki V, Hoerstrup SP, Kadner A, Schoeberlein A et al. Heat shock protein upregulation lowers cytokine levels after ischemia and reperfusion. Eur Surg Res 2001; 33: 383-7.
44. Sarcia PJ, Scumpia PO, Moldawer LL, DeMarco VG, Skimming JW. Hypothermia induces interleukin-10 and attenuates injury in the lungs of endotoxemic rats. Shock 2003; 20: 41-5.
45. Han HS, Karabiyikoglu M, Kelly S, Sobel RA, Yenari MA. Mild hypothermia inhibits nuclear factor-kappaB translocation in experimental stroke. J Cereb Blood Flow Metab 2003; 23: 589-98.
46. Matsuoka K, Ueno T, Morita K, Kawano H, Yamaguchi K, Maekawa T et al. Effects of moderate hypothermia on proinflammatory cytokine production in a rat model of caerulein-induced pancreatitis. Pancreas 2003; 26: 12-7.